nach oben

Archives of Virology

Erschienen in:

01.01.2012 | Original Article

Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71

verfasst von: Qunying Mao, Nan Li, Xiang Yu, Xin Yao, Fengxiang Li, Fengmin Lu, Hui Zhuang, Zhenglun Liang, Junzhi Wang

Erschienen in: Archives of Virology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Enterovirus 71 (EV71) is one of the major causative agents of hand, foot and mouth disease. Recently, several EV71 inactivated vaccine candidates have been development in mainland China. To compare the antigenicity and genetic characteristics of different candidate vaccine strains for EV71, the genomes of 11 EV71 strains were sequenced. The cross-protection capacities were determined by neutralizing antibody test and were further assessed in neonatal mice. The results showed 93.0%–99.8% genome homology of the VP1 regions, but their cross-neutralization capacities varied. These results showed that vaccine strains with good cross-neutralization capacities had the potential to be vaccine strains.

Nur mit Berechtigung zugänglich

Schmidt NJ, Lennette EH, Ho HH (1974) An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 129:304–309PubMedCrossRef

Chen SC, Chang HL, Yan TR, Cheng YT, Chen KT (2007) An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg 77:188–191PubMed

National notifiable diseases announced by Ministry of Health of the People’s Republic of china. http://www.moh.gov.cn/publicfiles/business/htmlfiles/wsb/pyqxx/list.htm

(2009) Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines, February 2009. Wkly Epidemiol Rec 84:72–76

Lee MS, Chang LY (2010) Development of enterovirus 71 vaccines. Expert Rev Vaccines 9:149–156PubMedCrossRef

Liu CC, Guo MS, Lin FH, Hsiao KN, Chang KH, Chou AH, Wang YC, Chen YC, Yang CS, Chong PC (2011) Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system. PLoS One 6:e20005PubMedCrossRef

Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS (2002) Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20:895–904CrossRef

Yao X, Mao QY, Huang WJ, He P, Zhou C, Zhang W, Liang ZL, Li FX, Wang JZ (2009) Genetic characterization of enterovirus 71 complete genome isolated in Beijing, 2008. Zhonghua Liu Xing Bing Xue Za Zhi 30:729–732PubMed

Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, Ji F, Wang XJ, Gao YJ, Chen L, An HQ, Li DX, Wang SW, Xu AQ, Wang ZJ, Xu WB (2009) An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol 44:262–267PubMedCrossRef

10.

Mizuta K, Aoki Y, Suto A, Ootani K, Katsushima N, Itagaki T, Ohmi A, Okamoto M, Nishimura H, Matsuzaki Y, Hongo S, Sugawara K, Shimizu H, Ahiko T (2009) Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine 27:3153–3158PubMedCrossRef

11.

van der Sanden S, van der Avoort H, Lemey P, Uslu G, Koopmans M (2010) Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses. J Gen Virol 91:1949–1958PubMedCrossRef

12.

Mao QY, He P, Yu X, Li N, Hao CS, Gao Q, Dong CH, Liang ZL, Li FX, Shen XL, Wang JZ (2010) Laboratory evaluation of method for determination of neutralizing antibody against human enterovirus. Chin J Biologicals 23:885–888

13.

Gomes Mde L, de Castro CM, Oliveira MJ, da Silva EE (2002) Neutralizing antibodies to enterovirus 71 in Belem, Brazil. Mem Inst Oswaldo Cruz 97:47–49PubMedCrossRef

14.

Kargar M, Sadeghipour S, Nategh R (2009) Environmental surveillance of non-polio enteroviruses in Iran. Virol J 6:149PubMedCrossRef

15.

Saeed M, Zaidi SZ, Naeem A, Masroor M, Sharif S, Shaukat S, Angez M, Khan A (2007) Epidemiology and clinical findings associated with enteroviral acute flaccid paralysis in Pakistan. BMC Infect Dis 7:6PubMedCrossRef

16.

Saraswathy TS, Khairullah NS, Sinniah M, Fauziah MK, Apandi MY, Shamsuddin M (2004) Laboratory acute flaccid paralysis surveillance in Malaysia: a decade of commitment to the WHO global polio eradication initiative. Southeast Asian J Trop Med Public Health 35:421–424PubMed

17.

WHO/EPI/CDS/POLIO/90.01 (1997) Manual for the virological investigation of poliomyelitis. http://whqlibdoc.who.int/hq/1997/WHO_EPI_GEN_97.01.pdf

18.

Chung YC, Huang JH, Lai CW, Sheng HC, Shih SR, Ho MS, Hu YC (2006) Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol 12:921–927PubMed

19.

Ong KC, Devi S, Cardosa MJ, Wong KT (2010) Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol 84:661–665PubMedCrossRef

20.

Chung YC, Ho MS, Wu JC, Chen WJ, Huang JH, Chou ST, Hu YC (2008) Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26:1855–1862PubMedCrossRef

Titel: Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71
verfasst von: Qunying Mao
Nan Li
Xiang Yu
Xin Yao
Fengxiang Li
Fengmin Lu
Hui Zhuang
Zhenglun Liang
Junzhi Wang
Publikationsdatum: 01.01.2012
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 1/2012
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-011-1136-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2012

Characterization of novel bovine papillomavirus type 12 (BPV-12) causing epithelial papilloma

A new begomovirus associated with alpha- and betasatellite molecules isolated from Vernonia cinerea in China

Encephalomyocarditis virus may use different pathways to initiate infection of primary human cardiomyocytes

Variability in the P1 gene helps to refine phylogenetic relationships among leek yellow stripe virus isolates from garlic

Molecular characterization of a canine coronavirus NA/09 strain detected in a dog’s organs

Rescue of avian adeno-associated virus from a recombinant plasmid containing deletions in the viral inverted terminal repeats

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin